| Primary |
| Depression |
35.7% |
| Fibromyalgia |
10.0% |
| Embolism |
8.6% |
| Pain |
5.7% |
| Product Used For Unknown Indication |
5.7% |
| Insomnia |
4.3% |
| Major Depression |
4.3% |
| Anxiolytic Therapy |
2.9% |
| Embolism Arterial |
2.9% |
| Hypertension |
2.9% |
| Mental Disorder |
2.9% |
| Thought Insertion |
2.9% |
| Agitation |
1.4% |
| Anxiety |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Osteopenia |
1.4% |
| Osteoporosis |
1.4% |
| Overdose |
1.4% |
| Productive Cough |
1.4% |
| Pulmonary Embolism |
1.4% |
|
| Overdose |
9.4% |
| Serotonin Syndrome |
9.4% |
| Tachycardia |
9.4% |
| Cardiomyopathy |
6.3% |
| Syncope |
6.3% |
| Tardive Dyskinesia |
6.3% |
| Urinary Retention |
6.3% |
| Vomiting |
6.3% |
| Weight Decreased |
6.3% |
| Abdominal Pain Upper |
3.1% |
| Akinesia |
3.1% |
| Bifascicular Block |
3.1% |
| Confusional State |
3.1% |
| Creatinine Renal Clearance Decreased |
3.1% |
| Dizziness |
3.1% |
| Dyspnoea Exertional |
3.1% |
| Feeling Abnormal |
3.1% |
| Gait Disturbance |
3.1% |
| Hypersexuality |
3.1% |
| Immune Thrombocytopenic Purpura |
3.1% |
|
| Secondary |
| Depression |
26.6% |
| Product Used For Unknown Indication |
18.9% |
| Fibromyalgia |
14.6% |
| Pain |
5.7% |
| Drug Use For Unknown Indication |
3.7% |
| Hypertension |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Antidepressant Therapy |
2.9% |
| Cervicogenic Headache |
2.3% |
| Major Depression |
2.3% |
| Panic Disorder |
2.0% |
| Diabetic Neuropathy |
1.7% |
| Insomnia |
1.7% |
| Migraine |
1.7% |
| Myofascial Pain Syndrome |
1.7% |
| Panic Attack |
1.7% |
| Depressed Mood |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Neuralgia |
1.4% |
| Osteopenia |
1.4% |
|
| Serotonin Syndrome |
22.9% |
| Weight Decreased |
9.6% |
| Toxicity To Various Agents |
7.2% |
| Tremor |
7.2% |
| Vomiting |
6.0% |
| Polychondritis |
4.8% |
| Sinus Bradycardia |
4.8% |
| Spinal Column Injury |
4.8% |
| Drug Abuse |
3.6% |
| Overdose |
3.6% |
| Tension |
3.6% |
| Death |
2.4% |
| Depression |
2.4% |
| Malaise |
2.4% |
| Mood Altered |
2.4% |
| Palpitations |
2.4% |
| Renal Failure |
2.4% |
| Restlessness |
2.4% |
| Suicide Attempt |
2.4% |
| Tachycardia |
2.4% |
|
| Concomitant |
| Fibromyalgia |
18.0% |
| Depression |
14.3% |
| Product Used For Unknown Indication |
9.0% |
| Hypertension |
8.0% |
| Drug Use For Unknown Indication |
5.0% |
| Pain |
5.0% |
| Anxiety |
4.3% |
| Major Depression |
4.0% |
| Type 2 Diabetes Mellitus |
4.0% |
| Rheumatoid Arthritis |
3.7% |
| Blood Cholesterol Increased |
3.3% |
| Osteoporosis |
3.3% |
| Multiple Sclerosis |
2.7% |
| Breast Cancer |
2.3% |
| Hormone Replacement Therapy |
2.3% |
| Hypothyroidism |
2.3% |
| Insomnia |
2.3% |
| Blood Pressure |
2.0% |
| Diabetes Mellitus Non-insulin-dependent |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
|
| Suicidal Ideation |
10.0% |
| Weight Decreased |
10.0% |
| Pyrexia |
7.1% |
| Weight Increased |
7.1% |
| Musculoskeletal Stiffness |
5.7% |
| Renal Failure Acute |
5.7% |
| Stupor |
5.7% |
| Tremor |
5.7% |
| Deep Vein Thrombosis |
4.3% |
| Drug Ineffective |
4.3% |
| Poor Peripheral Circulation |
4.3% |
| Serotonin Syndrome |
4.3% |
| Somnolence |
4.3% |
| Vision Blurred |
4.3% |
| Abdominal Pain Upper |
2.9% |
| Back Pain |
2.9% |
| Drug Exposure During Pregnancy |
2.9% |
| Hyperhidrosis |
2.9% |
| Intracranial Aneurysm |
2.9% |
| Loss Of Consciousness |
2.9% |
|
| Interacting |
| Back Pain |
19.0% |
| Aortic Valve Replacement |
16.7% |
| Bipolar Disorder |
14.3% |
| Blood Cholesterol Increased |
11.9% |
| Hypertension |
11.9% |
| Anxiety |
9.5% |
| Irritable Bowel Syndrome |
9.5% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Fibromyalgia |
2.4% |
| Smoking Cessation Therapy |
2.4% |
|
| Drug Interaction |
61.5% |
| Rash |
30.8% |
| White Blood Cell Count Increased |
7.7% |
|
